Foghorn Therapeutics Shares Plunge Amid Heavy Selling Pressure

Key Facts

Foghorn Therapeutics shares experienced a sharp decline in value during today's trading session. Investing.com reported that the stock faced heavy selling pressure, continuing a period of significant volatility for the biotechnology firm.

This price action follows a session where FHTX closed at $2.92 on October 1, 2026. During that period, the stock reached a high of $3.21 and a low of $1.79, reflecting the volatile trading range preceding the current downward movement.